Anti-A isoagglutinin as a risk factor for the development of pure red cellaplasia after major ABO-incompatible allogeneic bone marrow transplantation

Delayed erythropoiesis and pure red cell aplasia (PRCA) have been reported after major ABO-incompatible BMT. We attempted to find risk factors for the development of PRCA in 27 patients who underwent major ABO-incompatible BM T, In all patients, the donor marrow was depleted of RBCs before infusion. In 22 patients, isoagglutinins were determined until they disappeared. In e ight (29.6%) out of 27 patients, bone marrow examination following BMT show ed the findings of PRCA, We analyzed various clinico-pathologic risk factor s and isoagglutinin type was the only significant risk factor. Patients wit h anti-A isoagglutinins against donor RBC developed PRCA more frequently th an patients with anti-B (8/17 vs 0/9), Median days to the disappearance of isoagglutinins tended to be longer in patients with PRCA (PRCA vs non-PRCA, 200 vs 66 days) and in cases with anti-A isoagglutinins (anti-A vs anti-B, 160 vs 51 days). Times to disappearance of isoagglutinins correlated with times to reticulocytes over 1% and initial appearance of donor type RBC (R- 2 = 0.708 and 0.711), In conclusion, RBC engraftment following major ABO-in compatible BMT was dependent on the disappearance of isoagglutinins against donor RBC, and anti-A isoagglutinin was a risk factor for the development of PRCA after major ABO-incompatible allogeneic BMT.